PRKN and serum lipopolysaccharide activity: According to previously established protocol (Sun et al., 2018b), we determined whether introducing Parkin mutation W402A affected cardiac mitophagy in the endotoxemia model by examining mitochondria-lysosome association and the levels of mitophagy/autophagy factors located at mitochondria.